FORTUNE — It’s been a busy few days for IPOs, and things only are expected to heat up next week.
Seven companies have priced on U.S. exchanges since Tuesday, including last night’s $191 million raise for digital coupon marketplace RetailMeNot (SALE). It hopes to mimic the 60% aftermarket bump achieved yesterday by cancer “stem cell” company OncoMed Pharmaceuticals (OMED).
On tap next week are a whopping eleven offerings:
Next week’s calender doesn’t include anything huge, but it could be interesting to see if OncoMed provides any halo effect to any of the five VC-backed biotechs. I’d expect us to see some larger offerings come fall, which is when IPO volume traditionally increases.
Some additional IPO thoughts from an interview I did this morning on CNBC: